Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Economic News/Analysis

Global Dental Implants Market Report 2022: Growing Concern for Oral Healthcare Boosting Sector - ResearchAndMarkets.com


The "Global Dental Implants Market: Analysis By Material (Titanium, Zirconium & Other), By Product (Endosteal, Subperiosteal, Transosteal & Others), By Design (Tapered & Parallel Walled), By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2027" report has been added to ResearchAndMarkets.com's offering.

The global dental implants market was valued at US$4.22 billion in 2021, and is expected to be worth US$6.08 billion in 2027. Dental implants are referred to the artificial tooth roots, made of materials such as titanium or zirconium, that could be inserted into the jaw. They not only enable for the aesthetic and functional replacement of lost teeth, but also for the preservation of jaw structure by avoiding bone resorption or atrophy.

Dental implants do not need the grinding down of healthy nearby teeth, do not cause discomfort while eating or speaking, and are long-lasting with a natural appearance as compared to traditional fixed bridges or dentures. The preference for dental implants as a treatment option over conventional devices such as crowns, bridges, or dentures is therefore unsurprising. The global dental implants market is determined to grow at a CAGR of 6.54% over the forecasted period of 2022-2027.

Market Segmentation Analysis:

Asia Pacific is predicted to grow at a significantly high rate due to a large patient base and the expanding use of advanced implants in dentistry. Additionally, the expansion of medical tourism in Singapore, China, and India is probably going to favor the market growth in the region.

Market Dynamics:

Growth Drivers

Challenges

Market Trends

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Regional Market Analysis

5. Impact of Covid-19

6. Market Dynamics

7. Competitive Landscape

8. Company Profiles

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/soqxzm


These press releases may also interest you

at 06:00
BioInvent International (STO:BINV)Preliminary data presented at ESMO 2024 demonstrate BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatmentIn a patient with a heavily pretreated leiomyosarcoma, BT-001 was able to...

at 05:18
Mox Capital, a trailblazer in alternative investments with AUM of US$1.4 billion, is announcing its strategic support for a vast array and variety of regional high-potential startups. According to COO Nguyen Dinh Giang, Mox Capital seeks to reinforce...

at 05:00
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials;...

at 04:20
Pfizer Inc. today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for patients with BRAF V600E-mutant...

at 04:06
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced the latest clinical data on...

at 04:05
Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This...



News published on and distributed by: